Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy.

Abstract

Cardiac resynchronization therapy (CRT) is an established therapy for heart failure patients who remain symptomatic despite optimal medical therapy, have reduced left ventricular ejection fraction (<35%) and wide QRS duration (>120 ms), preferably with left bundle branch block morphology. The response to CRT depends on the cardiac substrate: presence of correctable left ventricular mechanical dyssynchrony, presence of myocardial fibrosis (scar) and position of the left ventricular pacing lead. Patients with non-ischemic cardiomyopathy have shown higher response rates to CRT compared with patients with ischemic cardiomyopathy. Differences in myocardial substrate may partly explain this disparity. Multimodality imaging plays an important role to assess the cardiac substrate and the pathophysiological determinants of response to CRT.

• Authors: Miriam Shanks, Victoria Delgado, Jeroen J Bax
• Journal: Journal of atrial fibrillation (J Atr Fibrillation) 2016 Feb-Mar Vol. 8 Issue 5 Pg. 1362 ISSN: 1941-6911 [Print] United States
• PMID: 27909478 (Publication Type: Review, Journal Article)